Pharma-Bio Serv (PBSV) Other financing activities (2021 - 2024)

Pharma-Bio Serv's Other financing activities history runs 4 years deep, the most recent figure standing at $1.0 for Q1 2024.

• Quarterly Other financing activities changed N/A year-over-year to $1.0 in Q1 2024, while the trailing twelve-month figure through Apr 2024 was $6.0 (down 25.0% YoY) and the FY2023 annual result came in at $5.0, up 66.67% from the prior year.
• Other financing activities was $1.0 for Q1 2024 at Pharma-Bio Serv, down from $5.0 in the prior quarter.
• Across five years, Other financing activities topped out at $5.0 in Q2 2023 and bottomed at $1.0 in Q1 2024.
• A 4-year average of $2.75 and a median of $2.5 in 2021 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 50.0% in 2022, while the deepest fall reached 50.0% in 2022.
• Pharma-Bio Serv's Other financing activities stood at $2.0 in 2021, then soared by 50.0% to $3.0 in 2022, then surged by 66.67% to $5.0 in 2023, then sank by 80.0% to $1.0 in 2024.
• Business Quant data shows PBSV's Other financing activities at $1.0 in Q1 2024, $5.0 in Q2 2023, and $3.0 in Q1 2022.